ClinicalTrials.Veeva

Menu

Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease

N

Nanfang Hospital, Southern Medical University

Status

Not yet enrolling

Conditions

Crohn Disease of Small Intestine
Inflammatory Bowel Diseases
Digestive System Disease
Crohn Disease

Study type

Observational

Funder types

Other

Identifiers

NCT05636657
NFEC-2022-346

Details and patient eligibility

About

The disease activity index under intestinal color ultrasound was evaluated by SUS-CD, and the disease activity index under capsule endoscopy was evaluated by CECDAI. All subjects underwent intestinal color ultrasound and capsule endoscopy at baseline and at the third month of treatment. To compare the correlation between SUS-CD and CECDAI before and after treatment, and to compare the role of intestinal color ultrasound and capsule endoscopy in monitoring Crohn's disease in small intestine.

Full description

The disease activity index under intestinal color ultrasound was evaluated by SUS-CD, and the disease activity index under capsule endoscopy was evaluated by CECDAI. Active lesions under intestinal color ultrasound were defined as SUS-CD ≥ 1, and active lesions under capsule endoscopy were defined as CECDAI ≥ 3.9. All subjects underwent intestinal color ultrasound and capsule endoscopy at baseline and 3 months after treatment. To compare the correlation between SUS-CD and CECDAI before and after treatment, and to compare the role of intestinal color ultrasound and capsule endoscopy in monitoring Crohn's disease in small intestine.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1.Patients diagnosed with Crohn's disease according to the 2019 European Guidelines for Crohn's disease;
  • 2.At the time of inclusion, there were active lesions under color ultrasound or capsule endoscopy;
  • 3.Voluntarily sign an informed consent form.

Exclusion criteria

  • 1.Patients with contraindications for capsule endoscopy;
  • 2.In the judgment of the investigator, it is not suitable to participate in this study.

Trial contacts and locations

1

Loading...

Central trial contact

Xinmei Zhao, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems